Cara Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 14,996 | 0.0274% |
Individual Insiders | 491,282 | 0.899% |
General Public | 13,626,050 | 24.9% |
Public Companies | 14,793,540 | 27.1% |
Institutions | 25,741,211 | 47.1% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
7,396,770 | US$5.2m | 0% | no data | |||
7,396,770 | US$5.2m | 0% | no data | |||
3,554,258 | US$2.5m | -4.15% | no data | |||
2,631,067 | US$1.9m | 1.26% | no data | |||
1,812,100 | US$1.3m | 2.24% | 0.02% | |||
1,752,112 | US$1.2m | -0.26% | 0.24% | |||
1,556,251 | US$1.1m | -6.62% | 0.01% | |||
1,020,878 | US$721.9k | 10.3% | no data | |||
1,008,959 | US$713.4k | 3.71% | no data | |||
909,177 | US$642.9k | 11.1% | 0.25% | |||
831,849 | US$588.2k | 3.53% | no data | |||
828,799 | US$586.0k | 28.1% | no data | |||
697,030 | US$492.9k | 123% | no data | |||
696,868 | US$492.8k | -51.7% | no data | |||
637,107 | US$450.5k | 66.4% | no data | |||
550,029 | US$388.9k | 41% | no data | |||
514,200 | US$363.6k | 274% | no data | |||
467,187 | US$330.3k | -39.7% | no data | |||
391,812 | US$277.0k | -6.09% | no data | |||
360,473 | US$254.9k | 57.6% | no data | |||
313,058 | US$221.4k | 59.4% | no data | |||
307,271 | US$217.3k | 340% | no data | |||
292,854 | US$207.1k | 337% | no data | |||
275,335 | US$194.7k | 207% | no data | |||
268,618 | US$189.9k | 0% | no data |